WADA is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
Sodium dodecyl sulfate (SDS), a common detergent, may be found in protein extracts because it is used to lyse cells by disrupting the membrane lipid bilayer and to denature proteins for SDS-PAGE. While other detergents interfere with the assay at high concentration, the interference caused by SDS is of two different modes, and each occurs at a different concentration. When SDS concentrations are below critical micelle concentration (known as CMC, 0.00333%W/V to 0.0667%) in a Coomassie dye solution, the detergent tends to bind strongly with the protein, inhibiting the protein binding sites for the dye reagent. This can cause underestimations of protein concentration in solution. When SDS concentrations are above CMC, the detergent associates strongly with the green form of the Coomassie dye, causing the equilibrium to shift, thereby producing more of the blue form. This causes an increase in the absorbance at 595 nm independent of protein presence. Other interference may come from the buffer used when preparing the protein sample. A high concentration of buffer will cause an overestimated protein concentration due to depletion of free protons from the solution by conjugate base from the buffer. This will not be a problem if a low concentration of protein (subsequently the buffer) is used. In order to measure the absorbance of a colorless compound a Bradford assay must be performed.
Kane, a scientist at Pfizer, suggested using a deep-tank fermentation method for producing large quantities of pharmaceutical-grade penicillin. Large-scale production resulted from the development of a deep-tank fermentation plant by the chemical engineer Margaret Hutchinson Rousseau. As a direct result of the war and the War Production Board, by June 1945 over 646 billion units per year were being produced. G. Raymond Rettew made a significant contribution to the American war effort by his techniques to produce commercial quantities of penicillin, wherein he combined his knowledge of mushroom spawn with the function of the Sharples Cream Separator. By 1943 Rettew's lab was producing most of the world's penicillin. During the Second World War penicillin made a major difference in the number of deaths and amputations caused by infected wounds amongst Allied forces, saving an estimated 12–15% of lives. Availability was severely limited, however, by the difficulty of manufacturing large quantities of penicillin and by the rapid renal clearance of the drug, necessitating frequent dosing. Methods for mass production of penicillin were patented by Andrew Jackson Moyer in 1945. Florey had not patented penicillin, having been advised by Sir Henry Dale that doing so would be unethical. Penicillin is actively excreted, and about 80% of a penicillin dose is cleared from the body within three to four hours of administration.
Tokusou Sentai Dekaranger (特捜戦隊デカレンジャー, Tokusō Sentai Dekarenjā) is a Japanese tokusatsu series that serves as the 28th installment in the Super Sentai franchise and the 16th entry in the Heisei era. In an iteration of the planet Earth where extraterrestrial contact is possible, the S.P.D. (Special Police Dekaranger) battles alien criminals collectively called "Alienizers".
Trump also indicated that what he called the UK's "stupidity" in transferring the Chagos Islands to Mauritius justified his demands on Greenland. Trump posted an image of a map showing Canada and Greenland as part of the US and an AI image of him along with JD Vance and Marco Rubio planting a US flag on Greenlandic soil. On 21 January, Trump had asked the chairman of the Joint Chiefs of Staff Dan Caine to present potential options and the impacts of using military force to seize Greenland, ultimately resulting in Trump deciding against an invasion, Trump administration officials told NBC News.
Sources: en.wikipedia.org
== Effects == The effects of strength training include greater muscular strength, improved muscle tone and appearance, increased endurance, cardiovascular health, and enhanced bone density. These benefits contribute not only to athletic performance but also to long-term health and independence, especially as individuals age. Regular resistance training supports metabolic function, helps regulate body weight, and can improve mental well-being through the release of endorphins.
The electoral process for the president was also changed, from being directly elected by the Togolese people to being indirectly elected by the Parliament. Opposition members criticised these changes due to the lack of term limits for Gnassingbé's new position. The changes came into effect in May 2025, when Gnassingbé was sworn in as president of the Council of Ministers, with former opposition leader Jean-Lucien Savi de Tové becoming president. Since June 2025, protests against Gnassingbé grew demanding his resignation. Gnassingbé has been widely criticized for contributing to democratic backsliding in Togo and critics have described him as a dictator.
=== Melting and boiling points === Electrostatic forces between particles are strongest when the charges are high, and the distance between the nuclei of the ions is small. In such cases, the compounds generally have very high melting and boiling points and a low vapour pressure. Trends in melting points can be even better explained when the structure and ionic size ratio is taken into account. Above their melting point, salts melt and become molten salts (although some salts such as aluminium chloride and iron(III) chloride show molecule-like structures in the liquid phase). Inorganic compounds with simple ions typically have small ions, and thus have high melting points, so are solids at room temperature. Some substances with larger ions, however, have a melting point below or near room temperature (often defined as up to 100 °C), and are termed ionic liquids. Ions in ionic liquids often have uneven charge distributions, or bulky substituents like hydrocarbon chains, which also play a role in determining the strength of the interactions and propensity to melt. Even when the local structure and bonding of an ionic solid is disrupted sufficiently to melt it, there are still strong long-range electrostatic forces of attraction holding the liquid together and preventing ions boiling to form a gas phase. This means that even room temperature ionic liquids have low vapour pressures, and require substantially higher temperatures to boil. Boiling points exhibit similar trends to melting points in terms of the size of ions and strength of other interactions.
In 1899 Lore Rogers was offered a position as assistant bacteriologist at the New York State Agricultural Experiment Station, Geneva. The New York State Legislature had established the State Agricultural Experiment Station, which opened in 1882. It was no coincidence that two bacteriologists overlapped at Wisconsin and arrived at the experiment station in 1899. Harry Alexis Harding had been an undergraduate and graduate student at Wisconsin under H. L. Russell (and would later earn a PhD at Cornell University). Harding, with his Wisconsin M.S. degree followed by study in Europe, was appointed chief dairy bacteriologist, and Lore would serve as assistant. The experiment station staff around 1900 included a superintendent, an animal industry specialist, two botanists, eight chemists, two bacteriologists, a dairy expert, three entomologists, three horticulturalists, an editor-librarian, and two clerk-stenographers. The two bacteriologists, Harry Harding, and Lore Rogers, collaborated on several reports on milk and cheese, with Harding listed as senior author. George A. Smith,"dairy expert" was another collaborator. Some station bulletins co-authored by Lore Rogers included "The Efficiency of a Continuous Pasteurizer at Different Temperatures" (1899), "Inspection of Babcock Milk Test Bottles" (1900), "Dairy Disagreeables Busy the Bacteriologists" (1900), and "Notes on Some Dairy Troubles" (1900).
Brewing yeasts may be classed as "top-cropping" (or "top-fermenting") and "bottom-cropping" (or "bottom-fermenting"). Top-cropping yeasts are so called because they form a foam at the top of the wort during fermentation. An example of a top-cropping yeast is Saccharomyces cerevisiae, sometimes called an "ale yeast". Bottom-cropping yeasts are typically used to produce lager-type beers, though they can also produce ale-type beers. These yeasts ferment well at low temperatures. An example of bottom-cropping yeast is Saccharomyces pastorianus, formerly known as S. carlsbergensis. Decades ago, taxonomists reclassified S. carlsbergensis (uvarum) as a member of S. cerevisiae, noting that the only distinct difference between the two is metabolic. Lager strains of Saccharomyces secrete an enzyme called melibiase, allowing them to hydrolyse melibiose, a disaccharide, into more fermentable monosaccharides. Top- and bottom-cropping and cold- and warm-fermenting distinctions are largely generalizations used by laypersons to communicate to the general public. The most common top-cropping brewer's yeast, S. cerevisiae, is the same species as the common baking yeast. Brewer's yeast is also very rich in essential minerals and the B vitamins (except B12), a feature exploited in food products made from leftover (by-product) yeast from brewing.
Sources: en.wikipedia.org
Margot Kidder at IMDb Margot Kidder at the Internet Off-Broadway Database (archived) Article at thecanadianencyclopedia.ca Article: From paranoid delusions to orthomolecular medicine Archived May 14, 2011, at the Wayback Machine Canadian Film Encyclopedia The Best Damn Fiddler from Calabogie to Kaladar Brodesser-Akner, Taffy. "Margot Kidder," New York Times, December 27, 2018.
=== Pharmacokinetics === Like many nucleoside analogues, FIAU is not active right away, it first needs to be converted inside liver cells to become active. In the liver FIAU is converted to its triphosphate form, which is the form that can be used by polymerases. FIAU is the de-aminated product of fiacitabine (FIAC). Upon the entering of FIAC into the cell, cytosine nucleoside deaminase de-aminates FIAC to FIAU.
A primordial element is a chemical element with at least one primordial nuclide. There are 251 stable primordial nuclides and 35 radioactive primordial nuclides, but only 80 primordial stable elements—hydrogen through lead, atomic numbers 1 to 82, except for technetium (43) and promethium (61)—and three radioactive primordial elements—bismuth (83), thorium (90), and uranium (92). If plutonium (94) turns out to be primordial (specifically, the long-lived isotope 244Pu), then it would be a fourth radioactive primordial, though practically speaking it would still be more convenient to produce synthetically. Bismuth's half-life is so long that it is often classed with the 80 stable elements instead, since its radioactivity is not a cause for concern. The number of elements is smaller than the number of nuclides, because many of the primordial elements are represented by multiple isotopes. See chemical element for more information.
== External links == Clinical trial number NCT05662332 for "A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) (QWINT-1)" at ClinicalTrials.gov Clinical trial number NCT05362058 for "A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-2)" at ClinicalTrials.gov Clinical trial number NCT05275400 for "A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin" at ClinicalTrials.gov Clinical trial number NCT05462756 for "A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections (QWINT-4)" at ClinicalTrials.gov
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.